ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Seventeen of 23 CHOPs Approved For Implementation

July 16, 1982

Texts Of Workshop Report Summarized

November 8, 1996

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

Stop Suffering And Death “All Around Us”? Von Eschenbach Speeches At FDA Omit 2015 Goal.

February 17, 2006

ASCO, AACR Nursing Society Programs Set

May 6, 1977

Fred Hutchinson Director Lee Hartwell To Retire Next Year; Board Begins Search

July 3, 2009